CoSyne Therapeutics

CoSyne Therapeutics is a drug discovery company applying AI and computational methods to identify and develop therapeutics for neurological diseases.

The company describes its approach as polymathic AI, integrating models across biology, chemistry, and genomics to generate and prioritise drug targets.

CoSyne operates a model, spinning out individual drug assets into subsidiaries to distribute portfolio risk. It has two active programmes at early discovery stage, targeting neurological conditions described as underserved by existing research.